iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference

Simply Wall St.12-03

iRhythm Technologies (IRTC) just used a major cardiac conference to show that its Zio ECG patch performs similarly for Asian and non Asian patients, a data driven win for its global expansion story. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588013769?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","is_english":true,"pubTime":"2025-12-03 15:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588013769","market":"nz","top_or_hot":-1,"title":"iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference","media":"Simply Wall St.","content":"<div>\n<p>iRhythm Technologies (IRTC) just used a major cardiac conference to show that its Zio ECG patch performs similarly for Asian and non Asian patients, a data driven win for its global expansion story. ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-03 15:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>iRhythm Technologies (IRTC) just used a major cardiac conference to show that its Zio ECG patch performs similarly for Asian and non Asian patients, a data driven win for its global expansion story. ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4563","symbol_name":"昨日强势股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg","article_id":"2588013769","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-irtc/irhythm-technologies/news/irhythm-technologies-irtc-valuation-after-new-global-zio-ecg","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2588013769","pubTimestamp":1764746347,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"iRhythm Technologies (IRTC) just used a major cardiac conference to show that its Zio ECG patch performs similarly for Asian and non Asian patients, a data driven win for its global expansion story.\nSee our latest analysis for iRhythm Technologies.\nThat backdrop helps explain why, even after a softer patch with a recent pullback in the 7 day share price return and some consolidation in the past month, iRhythm’s year to date share price return of over 100% and robust 1 year total shareholder...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4563":"昨日强势股","BK4082":"医疗保健设备","BK4129":"建筑与工程","ECG":"Everus Construction Group, Inc.","IRTC":"Irhythm Technologies Inc."},"translate_title":"主要心脏会议提供新的全球Zio ECG数据后iRhythm Technologies(IRTC)估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ECG":1.5,"IRTC":1.5},"content_text":"iRhythm Technologies (IRTC) just used a major cardiac conference to show that its Zio ECG patch performs similarly for Asian and non Asian patients, a data driven win for its global expansion story. See our latest analysis for iRhythm Technologies. That backdrop helps explain why, even after a softer patch with a recent pullback in the 7 day share price return and some consolidation in the past month, iRhythm’s year to date share price return of over 100% and robust 1 year total shareholder return suggest momentum is still very much on the front foot as investors reassess its growth runway and risk profile. If this kind of clinical validation has you thinking more broadly about the sector, it could be a good moment to explore healthcare stocks as potential next ideas. With the shares still trading below consensus targets and growth re accelerating, investors are asking whether iRhythm’s surge is only mid cycle or if the recent rally already reflects years of future expansion. AdvertisementMost Popular Narrative Narrative: 17.3% Undervalued With iRhythm Technologies closing at $181.87 against a narrative fair value of $219.93, the valuation gap frames a punchy, growth-centric story. Expansion into international markets (UK, EU, Japan), where iRhythm is seeing strong early uptake and building clinical validation, diversifies revenue streams and positions the company for long-term topline growth as aging populations drive global demand for remote cardiac monitoring. Read the complete narrative. Want to see what powers that upside, beyond the headline conference buzz? The narrative leans on ambitious revenue compounding, rising margins and a premium future earnings multiple. Curious how those pieces fit together into that fair value call? Dive in to unpack the full set of assumptions behind this growth-heavy model. Result: Fair Value of $219.93 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, regulatory remediation costs and intensifying competition from new cardiac monitoring and AI driven entrants could squeeze margins and blunt the bullish growth narrative. Find out about the key risks to this iRhythm Technologies narrative. Another Lens on Valuation Our SWS DCF model paints a starkly different picture, putting iRhythm’s fair value at $68.34 versus the current $181.87 share price. This implies the stock may be significantly overvalued rather than 17.3% undervalued. Which story do you trust when sizing your position? Look into how the SWS DCF model arrives at its fair value. IRTC Discounted Cash Flow as at Dec 2025 Build Your Own iRhythm Technologies Narrative If you see the story differently or want to stress test the numbers yourself, you can build a custom narrative in just a few minutes: Do it your way. A great starting point for your iRhythm Technologies research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Ready for your next investment move? Do not stop at one opportunity. Use the Simply Wall St Screener now to uncover fresh, data backed ideas before the market fully prices them in.  Capitalize on mispriced potential by scanning these 933 undervalued stocks based on cash flows that still fly under most investors’ radars. Ride powerful innovation waves by targeting these 24 AI penny stocks shaping how businesses use automation and intelligence. Strengthen your income stream by focusing on these 14 dividend stocks with yields > 3% that combine yield with underlying business resilience.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if iRhythm Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588013769","isCrawlerRequest":true}